Skip to main content

Table 5 Association between lipid metabolism markers and immune cells in the microenvironment

From: Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes

Variable CD3+ T cells in the CT CD3+ T cells in the IM CD8+ T cells in the CT   CD8+ T cells in the IM Immunoscore
Low High P Low High P Low High P Low High P Low High P
CHO 4.97 (1.91–15.30) 4.90 (1.97–10.28) 0.801 5.00 (1.91–15.30) 4.82 (1.97–10.28) 0.487 4.88 (2.92–15.30) 4.88 (1.91–14.97) 0.796   4.93 (1.97–10.28) 4.86 (1.91–15.30) 0.990 4.98 (1.91–15.30) 4.80 (1.97–10.28) 0.386
TG 1.08 (0.44–4.83) 1.15 (0.52–5.82) 0.959 1.12 (0.44–4.83) 1.13 (0.52–5.82) 0.797 1.07 (0.53–4.92) 1.14 (0.44–5.82) 0.386 1.13 (0.52–5.82) 1.10 (0.44–3.76) 0.365 1.09 (0.44–4.92) 1.13 (0.52–5.82) 0.986
HDL-C 1.13 (0.59–2.73) 1.18 (0.30–2.19) 0.475 1.18 (0.59–2.73) 1.14 (0.30–2.17) 0.410 1.18 (0.68–2.73) 1.13 (0.30–2.43) 0.364 1.14 (0.30–2.19) 1.17 (0.59–2.73) 0.627 1.18 (0.59–2.73) 1.14 (0.30–2.17) 0.679
LDL-C 3.06 (0.77–13.48) 3.10 (0.80–126.10) 0.758 3.04 (0.77–13.48) 3.12 (0.80–126.10) 0.861 3.05 (0.77–126.10) 3.01 (0.80–13.48) 0.819 3.13 (0.80–126.10) 3.00 (0.77–13.48) 0.735 3.13 (0.77–126.10) 3.00 (0.80–8.56) 0.394
ApoA1 1.17 (0.58–2.06) 1.24 (0.44–2.11) 0.022 1.18 (0.58–1.77) 1.26 (0.44–2.11) 0.002 1.21 (0.58–2.11) 1.18 (0.44–2.06) 0.192 1.20 (0.44–2.06) 1.19 (0.63–2.11) 0.498 1.19 (0.58–2.06) 1.22 (0.44–2.11) 0.280
ApoB 0.97 (0.32–2.80) 0.98 (0.39–2.08) 0.828 0.97 (0.32–2.80) 0.97 (0.44–2.11) 0.929 0.97 (0.39–1.69) 0.97 (0.32–2.80) 0.408 0.97 (0.39–2.08) 0.97 (0.32–2.80) 0.832 0.98 (0.32–2.80) 0.96 (0.39–2.08) 0.801
  1. ApoA1 apolipoprotein A1, ApoB apolipoprotein B, CHO cholesterol, CT core of the tumor, HDL high-density lipoprotein, IM invasive margin, LDL low-density lipoprotein, TG triglyceride